Trial Profile
Safety and Clinical Activity of Lapatinib in Patients With HER2-positive Refractory Advanced Cancer: A Phase II Single Arm Prospective Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Lapatinib (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 16 Feb 2017 Status changed from recruiting to completed.
- 24 Jan 2015 New trial record